Twist Bioscience to Present at the 36th Annual J.P. Morgan Healthcare Conference

Download PDF

SAN FRANCISCO, Calif. – January 3, 2018 -- Twist Bioscience Corporation, a company enabling customers to succeed through its offering of rapid, high-quality synthetic DNA, today announced that Emily Leproust, Ph.D., chief executive officer, will present at the 36th Annual J.P. Morgan Healthcare Conference on Monday, January 8th at 11:00 a.m. Pacific Time in San Francisco.

About Twist Bioscience Corporation

At Twist Bioscience Corporation, we work in service of customers who are changing the world for the better. In fields such as medicine, agriculture, industrial chemicals and data storage, by using our synthetic DNA tools, our customers are developing ways to better lives and improve the sustainability of the planet. The faster our customers succeed, the better for all of us, and Twist Bioscience is uniquely positioned to help accelerate their efforts. 

Our innovative silicon-based DNA Synthesis Platform provides precision at a scale that is otherwise unavailable to our customers. Our platform technologies overcome inefficiencies and enable cost-effective, rapid, precise, high-throughput synthesis and sequencing, providing both the quality and quantity of the tools they need to rapidly realize the opportunity ahead. For more information about our products and services, please visit www.twistbioscience.com. Twist Bioscience is on Twitter. Sign up to follow our Twitter feed @TwistBioscience at https://twitter.com/TwistBioscience.

Contacts

Investor Contact: